SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-030507
Filing Date
2024-03-13
Accepted
2024-03-13 07:27:28
Documents
7
Period of Report
2024-03-13

Document Format Files

Seq Description Document Type Size
1 6-K asln_6-k_-_03132024_fina.htm 6-K 48288
2 EX-4.1 asln-ex4_1.htm EX-4.1 157320
3 EX-5.1 asln-ex5_1.htm EX-5.1 43534
4 EX-10.1 asln-ex10_1.htm EX-10.1 390541
5 EX-99.1 asln-ex99_1.htm EX-99.1 20466
6 GRAPHIC img183322545_0.jpg GRAPHIC 12654
7 GRAPHIC img220282798_0.jpg GRAPHIC 13511
  Complete submission text file 0000950170-24-030507.txt   697557
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 24744575
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)